C. Stefanutti

584 total citations
20 papers, 498 citations indexed

About

C. Stefanutti is a scholar working on Surgery, Hematology and Immunology. According to data from OpenAlex, C. Stefanutti has authored 20 papers receiving a total of 498 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Surgery, 6 papers in Hematology and 6 papers in Immunology. Recurrent topics in C. Stefanutti's work include Lipoproteins and Cardiovascular Health (15 papers), Blood Coagulation and Thrombosis Mechanisms (4 papers) and Cancer, Lipids, and Metabolism (4 papers). C. Stefanutti is often cited by papers focused on Lipoproteins and Cardiovascular Health (15 papers), Blood Coagulation and Thrombosis Mechanisms (4 papers) and Cancer, Lipids, and Metabolism (4 papers). C. Stefanutti collaborates with scholars based in Italy, Colombia and Czechia. C. Stefanutti's co-authors include Stefano Bertolini, S. Calandra, Silvia Langheim, Alfredo Cantàfora, Giovanni Mario Pes, Livia Pisciotta, S. Martini, Maurizio Averna, Stefania Basili and Pasquale Pignatelli and has published in prestigious journals such as European Heart Journal, Arteriosclerosis Thrombosis and Vascular Biology and Atherosclerosis.

In The Last Decade

C. Stefanutti

20 papers receiving 479 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Stefanutti Italy 10 339 153 118 89 79 20 498
Kazuhiko Makino Japan 9 373 1.1× 155 1.0× 151 1.3× 133 1.5× 57 0.7× 11 511
A. Vivenzio Italy 14 275 0.8× 147 1.0× 144 1.2× 50 0.6× 68 0.9× 27 425
Akito Kawaguchi Japan 13 309 0.9× 116 0.8× 214 1.8× 67 0.8× 36 0.5× 17 495
Michael S. Weinfeld United States 4 295 0.9× 95 0.6× 122 1.0× 128 1.4× 42 0.5× 5 444
Claudia Morozzi Italy 12 235 0.7× 77 0.5× 117 1.0× 54 0.6× 40 0.5× 19 332
John V. Mitsios Greece 13 202 0.6× 63 0.4× 170 1.4× 55 0.6× 57 0.7× 21 474
H.-J. Krebber Germany 4 373 1.1× 86 0.6× 240 2.0× 135 1.5× 84 1.1× 7 585
Elise F. Villard France 13 296 0.9× 117 0.8× 72 0.6× 112 1.3× 50 0.6× 16 437
Jan Willem F. Elte Netherlands 9 267 0.8× 317 2.1× 101 0.9× 34 0.4× 70 0.9× 12 642
O. Afanasieva Russia 15 459 1.4× 96 0.6× 230 1.9× 144 1.6× 141 1.8× 82 622

Countries citing papers authored by C. Stefanutti

Since Specialization
Citations

This map shows the geographic impact of C. Stefanutti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Stefanutti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Stefanutti more than expected).

Fields of papers citing papers by C. Stefanutti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Stefanutti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Stefanutti. The network helps show where C. Stefanutti may publish in the future.

Co-authorship network of co-authors of C. Stefanutti

This figure shows the co-authorship network connecting the top 25 collaborators of C. Stefanutti. A scholar is included among the top collaborators of C. Stefanutti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Stefanutti. C. Stefanutti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wiegman, Albert, Andrea Ruzza, Raúl D. Santos, et al.. (2022). Evolocumab treatment reduces carotid intima-media thickness in paediatric patients with heterozygous familial hypercholesterolaemia. European Heart Journal. 43(Supplement_2). 2 indexed citations
2.
Bianciardi, Giorgio, et al.. (2015). Platelet entropy is increased in familial hypercholesterolemia and in type 2 diabetic patients.. PubMed. 34(5). 489–94. 1 indexed citations
3.
Brunelli, Roberto, Marco De Spirito, Giampiero Mei, et al.. (2014). Misfolding of Apoprotein B-100, LDL Aggregation and 17-β -estradiol in Atherogenesis. Current Medicinal Chemistry. 21(20). 2276–2283. 10 indexed citations
4.
Stefanutti, C., et al.. (2013). Lipoprotein apheresis: State of the art and novelties. Atherosclerosis Supplements. 14(1). 19–27. 54 indexed citations
5.
Pignatelli, Pasquale, Roberto Carnevale, Roberto Cangemi, et al.. (2009). Atorvastatin Inhibits gp91phoxCirculating Levels in Patients With Hypercholesterolemia. Arteriosclerosis Thrombosis and Vascular Biology. 30(2). 360–367. 97 indexed citations
6.
Stefanutti, C., et al.. (2004). Therapeutic apheresis in low weight patients: technical feasibility, tolerance, compliance, and risks. Transfusion and Apheresis Science. 31(1). 3–10. 44 indexed citations
7.
Bertolini, Stefano, Livia Pisciotta, Lilla Di Scala, et al.. (2004). Genetic polymorphisms affecting the phenotypic expression of familial hypercholesterolemia. Atherosclerosis. 174(1). 57–65. 68 indexed citations
9.
Stefanutti, C., S. Di Giacomo, A. Vivenzio, et al.. (2001). Low‐density lipoprotein apheresis in a patient aged 3.5 years. Acta Paediatrica. 90(6). 694–701. 4 indexed citations
10.
Stefanutti, C., et al.. (2001). [LDL-apheresis: current status].. PubMed. 152(1). 65–9. 1 indexed citations
11.
Stefanutti, C., S. Di Giacomo, A. Vivenzio, et al.. (2001). Low-density lipoprotein apheresis in a patient aged 3.5 years. Acta Paediatrica. 90(6). 694–701. 22 indexed citations
12.
Bertolini, Stefano, Alfredo Cantàfora, Maurizio Averna, et al.. (2000). Clinical Expression of Familial Hypercholesterolemia in Clusters of Mutations of the LDL Receptor Gene That Cause a Receptor-Defective or Receptor-Negative Phenotype. Arteriosclerosis Thrombosis and Vascular Biology. 20(9). E41–52. 123 indexed citations
13.
Stefanutti, C., A Notarbartoló, V. Colloridi, et al.. (1997). LDL Apheresis in a Homozygous Familial Hypercholesterolemic Child Aged 4.5. Artificial Organs. 21(10). 1126–1127. 15 indexed citations
14.
Bertolini, Stefano, Rita Garuti, M. Rolleri, et al.. (1995). Four Novel Partial Deletions of LDL-Receptor Gene in Italian Patients With Familial Hypercholesterolemia. Arteriosclerosis Thrombosis and Vascular Biology. 15(1). 81–88. 22 indexed citations
15.
Stefanutti, C., et al.. (1995). Treatment of Homozygous and Double Heterozygous Familial Hypercholesterolemia Children with LDL-Apheresis. The International Journal of Artificial Organs. 18(2). 103–110. 16 indexed citations
16.
Garuti, Rita, Paola Pedrazzi, M. Ghisellini, et al.. (1994). A new missense mutation (Cys297?Phe) of the low density lipoprotein receptor in Italian patients with familial hypercholesterolemia (FHTrieste). Human Genetics. 93(5). 538–40. 4 indexed citations
17.
Coviello, Domenico, Stefano Bertolini, P Masturzo, et al.. (1993). Chorionic DNA analysis for the prenatal diagnosis of familial hypercholesterolaemia. Human Genetics. 92(4). 424–426. 5 indexed citations
18.
Stefanutti, C. & A. Vivenzio. (1993). [First prenatal diagnosis of familial hypercholesterolemia by a molecular biology technic].. PubMed. 143(2). 99–103. 1 indexed citations
19.
Gasparini, Daniele, et al.. (1990). [Isolated jejunal angiomatosis. A rare cause of intestinal hemorrhage].. PubMed. 45(23-24). 1477–9. 1 indexed citations
20.
Fanelli, Vito, et al.. (1986). [Effects of the integration of a habitual diet with glucomannan fiber in hypercholesterolemia. A clinical study in familial and sporadic hyperlipoproteinemia with lipo-proteic phenotype IIa and IIb].. PubMed. 119(1). 17–23. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026